Form 8-K - Current report:
SEC Accession No. 0001144204-15-038180
Filing Date
2015-06-22
Accepted
2015-06-19 19:27:41
Documents
7
Period of Report
2015-06-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v413656_8k.htm 8-K 17744
2 EXHIBIT 3.1 v413656_ex3-1.htm EX-3.1 2162
3 EXHIBIT 99.1 v413656_ex99-1.htm EX-99.1 12011
4 GRAPHIC image_002.jpg GRAPHIC 93015
5 GRAPHIC image_003.jpg GRAPHIC 77480
6 GRAPHIC image_004.jpg GRAPHIC 29428
7 GRAPHIC image_001.jpg GRAPHIC 41579
  Complete submission text file 0001144204-15-038180.txt   366713
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 15943419
SIC: 2834 Pharmaceutical Preparations